Pacer Advisors, Inc. Tandem Diabetes Care Inc Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$35.49 - $56.15 $179,650 - $284,231	5,062 Added 69.67%	12,328 $554,000
Q3 2022 Oct 18, 2022	BUY	$43.76 - $68.97 $317,960 - $501,136	7,266 New	7,266 $348,000
Q2 2022 Aug 12, 2022	SELL	$53.22 - $123.09 $78,925 - $182,542	-1,483 Closed	0 $0
Q1 2022 Apr 05, 2022	SELL	$101.89 - $150.09 $769,371 - $1.13 Million	-7,551 Reduced 83.58%	1,483 $172,000
Q4 2021 Feb 03, 2022	BUY	$118.18 - $153.21 $530,982 - $688,372	4,493 Added 98.94%	9,034 $1.36 Million
Q3 2021 Oct 15, 2021	BUY	$93.51 - $129.4 $424,628 - $587,605	4,541 New	4,541 $542,000

353

71.8M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.26B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.